Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Petruccioli (ROME, Italy), T. Chiacchio (ROME, Italy), V. Vanini (ROME, Italy), G. Cuzzi (ROME, Italy), F. Palmieri (ROME, Italy), L. Codecasa (MILAN, Italy), P. Castellotti (Milan, Italy), G. Ippolito (ROME, Italy), D. Goletti (ROME, Italy). Modulation of whole-blood IGRA response in patients with latent TB infection during treatment. 5272

Member's Comments

No comment yet.

Related content which might interest you: Modulation of QuantiFERON-TB-Gold Plus response in patients with active tuberculosis and latent infection during treatment Source: International Congress 2017 – Migrants and screening Year: 2017 Concordance between tuberculin skin testing and interferon-gamma release assays in diagnosis of latent tuberculosis infection among HIV-infected individuals Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012 Poor agreement between whole-blood IFN-? assay and TST for the diagnosis of latent TB infection in children Source: ISSN=ISSN 1810-6838, ISBN=, page=378 Year: 2007 Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 Interferon-γ release assays for the diagnosis of latent tuberculosis infection in HIV-seropositive individuals Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease Year: 2008 Characterization of the HBHA response in TB patients with or without HIV infection. Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017 Performance of the tuberculin skin test and Interferon-gamma release assays for detection of tuberculosis infection in immunocompromised patients in a TB endemic population Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 Value of QFT-IT test for diagnosing latent TB infection in HIV+ Source: ISSN=ISSN 1810-6838, ISBN=, page=284 Year: 2007 Comparison of whole-blood interferon-gamma release assay and tuberculin skin test results for the prediction of active tuberculosis disease in HIV-infected individuals Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 IFN-gamma response on T-cell based assays in HIV patients for detection of tuberculosis infection Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease Year: 2008 Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Comparison of a T-cell-based assay with tuberculin skin testing (TST) for diagnosis of latent tuberculosis infection (LTBI) in contact-tracing procedures Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI Year: 2005 Contribution of the T-SPOT.TB assay for differentiating active versus latent tuberculosis infection (LTBI) Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection Year: 2006 Predictive value of a whole-blood IGRA for the development of active TB disease Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease Year: 2008 Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Evaluation of IP-10 in blood serum for TB diagnosis in patients with late-stage HIV infection Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 The value of interferon-gamma releasing assays (IGRA) determining latent tuberculosis infection in renal transplant candidates Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Comparison between tuberculin skin testing and QuantiFERON Gold-In Tube for detection of latent tuberculosis in rheumatoid arthritis patients in a TB endemic population Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011